Related Articles for PubMed (Select 12890289)

17beta-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor.

Hamelers IH, Van Schaik RF, Sussenbach JS, Steenbergh PH.

Cancer Cell Int. 2003 Jul 11;3(1):10.

PMID: 12890289 [PubMed - as supplied by publisher]

Related Articles Free article in PMC

Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.

Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ.

Endocrinology. 2007 Aug;148(8):4091-101. Epub 2007 May 24.

PMID: 17525128 [PubMed - indexed for MEDLINE]

Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.

Hamelers IH, van Schaik RF, van Teeffelen HA, Sussenbach JS, Steenbergh PH.

Exp Cell Res. 2002 Feb 1;273(1):107-17.

PMID: 11795951 [PubMed - indexed for MEDLINE]

Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.

Cancer Res. 2001 Sep 15;61(18):6747-54.

PMID: 11559546 [PubMed - indexed for MEDLINE]

Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

Guvakova MA, Surmacz E.

Exp Cell Res. 1997 Feb 25;231(1):149-62.

PMID: 9056422 [PubMed - indexed for MEDLINE]

Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.

Huber M, Poulin R.

J Clin Endocrinol Metab. 1996 Jan;81(1):113-23.

PMID: 8550737 [PubMed - indexed for MEDLINE]

Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.

Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D.

J Cell Physiol. 1993 Nov;157(2):229-36.

PMID: 7693722 [PubMed - indexed for MEDLINE]

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.

Cancer Res. 2003 Feb 1;63(3):627-35.

PMID: 12566306 [PubMed - indexed for MEDLINE]

Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

Lee AV, Weng CN, Jackson JG, Yee D.

J Endocrinol. 1997 Jan;152(1):39-47.

PMID: 9014838 [PubMed - indexed for MEDLINE]

10:

Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.

Bentel JM, Lebwohl DE, Cullen KJ, Rubin MS, Rosen N, Mendelsohn J, Miller WH Jr.

J Cell Physiol. 1995 Oct;165(1):212-21.

PMID: 7559803 [PubMed - indexed for MEDLINE]

11:

IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.

Lin CW, Yang LY, Shen SC, Chen YC.

J Cell Physiol. 2007 Sep;212(3):666-74.

PMID: 17458902 [PubMed - indexed for MEDLINE]

12:

Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.

Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.

Clin Cancer Res. 2000 May;6(5):2028-36.

PMID: 10815929 [PubMed - indexed for MEDLINE]

13:

Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.

Ramamoorthy K, Wang F, Chen IC, Norris JD, McDonnell DP, Leonard LS, Gaido KW, Bocchinfuso WP, Korach KS, Safe S.

Endocrinology. 1997 Apr;138(4):1520-7.

PMID: 9075711 [PubMed - indexed for MEDLINE]

14:

Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.

van der Burg B, Isbrücker L, van Selm-Miltenburg AJ, de Laat SW, van Zoelen EJ.

Cancer Res. 1990 Dec 15;50(24):7770-4.

PMID: 2174732 [PubMed - indexed for MEDLINE]

15:

1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.

Swami S, Krishnan AV, Feldman D.

Clin Cancer Res. 2000 Aug;6(8):3371-9.

PMID: 10955825 [PubMed - indexed for MEDLINE]

16:

Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.

Herman ME, Katzenellenbogen BS.

J Steroid Biochem Mol Biol. 1996 Oct;59(2):121-34.

PMID: 9010327 [PubMed - indexed for MEDLINE]

17:

Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

Biswas DK, Averboukh L, Sheng S, Martin K, Ewaniuk DS, Jawde TF, Wang F, Pardee AB.

Mol Med. 1998 Jul;4(7):454-67.

PMID: 9713824 [PubMed - indexed for MEDLINE]

Recent Activity